Reduced Fluoroquinolone Susceptibility in Salmonella enterica Isolates from Travelers, Finland
Marianne M. Lindgren
, Pirkko Kotilainen, Pentti Huovinen, Saija Hurme, Susanna Lukinmaa, Mark A. Webber, Laura J.V. Piddock, Anja Siitonen, and Antti J. Hakanen
Author affiliations: National Institute of Health and Welfare, Turku, Finland (M.M. Lindgren, P. Kotilainen, P. Huovinen, A.J. Hakanen); Turku University Hospital, Turku (P. Kotilainen, A.J. Hakanen); University of Turku, Turku (S. Hurme); National Institute of Health and Welfare, Helsinki, Finland (S. Lukinmaa, A. Siitonen); University of Birmingham, Birmingham, UK (M.A. Webber, L.J.V. Piddock)
Main Article
Figure 2
Figure 2. Dendrogram showing the clonal relationships among 36 isolates of Salmonella enterica collected from travelers returning to Finland from Thailand or Malaysia, 2003–2007. These isolates showed the nonclassical quinolone resistance phenotype (i.e., reduced susceptibility to ciprofloxacin [MIC >0.125 µg/mL] and susceptibility or low-level resistance to nalidixic acid [MIC <32 µg/mL]). No., number of Salmonella isolates belonging to a certain pulsed-field gel electrophoresis (PFGE) pattern.
Main Article
Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.